JASON HARMON: Open Payments
NPI 1356339295 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,952 in 112 payments from 23 companies in 2025. Trend: 2023 $1,392 · 2024 $2,106 · 2025 $1,952
Food & beverage: $1,952
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $487 |
| Lilly USA, LLC | 14 | $217 |
| Novo Nordisk Inc | 13 | $214 |
| ABBVIE INC. | 15 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Dexcom, Inc. | 4 | $77 |
| Merit Medical Systems Inc | 1 | $70 |
| Abbott Laboratories | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
Products named: NURTEC ODT, ELIQUIS, JARDIANCE, Kerendia, QULIPTA, Ozempic, Dexcom G6 Transmitter, ESOPHYX.
Industry payments across AL — which companies pay providers there.
